We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KNEBV:OMXHEXKONE Oyj Class B Analysis

Data as of 2026-03-10 - not real-time

€56.80

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

KONE’s shares are trading below their 20‑day and 50‑day simple moving averages, indicating short‑term weakness. The 14‑day RSI sits in the low‑30s, suggesting the stock is approaching oversold territory. A bearish MACD histogram reinforces the downward momentum, while the price hovers just above the identified support level near €56. Volatility over the past 30 days exceeds 30 %, reflecting sizable price swings. Despite this, the computed beta of roughly 0.15 points to minimal correlation with broader market moves. The current market price also sits beneath the longer‑term 200‑day SMA, hinting at a potential trend reversal risk.
Fundamentally, KONE delivers strong profitability with ROE above 30 % and operating margins near 14 %. The dividend yield of over 3 % is attractive, though the payout ratio approaches 95 %, raising modest sustainability concerns. A discounted cash‑flow model values the company around €28, well below the €56.8 trading price, signaling an overvalued condition. The forward PE of roughly 23 contrasts with the trailing PE near 30, implying earnings improvement expectations. Industry‑adjusted valuation metrics are slightly above peers, reinforcing the premium pricing. Given the “Extreme Greed” sentiment index, investors may be overly optimistic, supporting a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • RSI indicating near‑oversold condition
  • bearish MACD signal

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • DCF valuation gap suggesting overvaluation
  • solid dividend yield
  • high ROE and operating margins

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • global market leadership in elevators and escalators
  • sustainable cash flow generation
  • attractive long‑term dividend with potential for price correction

Key Metrics & Analysis

Financial Health

Revenue Growth-0.50%
Profit Margin8.72%
P/E Ratio30.1
ROE34.69%
ROA9.33%
Debt/Equity30.77
P/B Ratio10.5
Op. Cash Flow€1.3B
Free Cash Flow€1.0B
Industry P/E29.4

Technical Analysis

TrendNeutral
RSI32.4
Support€56.26
Resistance€64.42
MA 20€61.39
MA 50€61.53
MA 200€57.67
MACDBearish
VolumeStable
Fear & Greed Index76.91

Valuation

Fair Value€28.52
Target Price€61.18
Upside/Downside7.71%
GradeOvervalued
TypeBlend
Dividend Yield3.19%

Risk Assessment

Beta0.15
Volatility31.76%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.